TRIOS HEALTH — History
CCN 500053 | 3-year financial timeline | COVID resilience: 59/100
🛡️ Public data only — no PHI permitted on this instance.
$155M
Latest Revenue (FY2022)
+1.8%
Revenue CAGR (3yr)
-10.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $149M | $167M | $155M | -7.2% | +1.8% |
| Operating Expenses | $171M | $177M | $171M | -3.8% | -0.2% |
| Operating Margin | -14.8% | -6.5% | -10.4% | -59.9% | +0.0% |
| Net Income | $-22M | $-11M | $-16M | -48.4% | +0.0% |
| Licensed Beds | 111 | 111 | 111 | +0.0% | +0.0% |
| Total Patient Days | 21,683 | 22,417 | 22,404 | -0.1% | +1.6% |
| Medicare Day % | 44% | 37% | 38% | +2.4% | -7.0% |
| Medicaid Day % | 7% | 5% | 4% | -22.4% | -26.0% |
COVID Impact & Recovery
Resilience Score: 59/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +3.6% ($149M → $155M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+1.8%
This Hospital
+7.6%
State Avg
Latest Margin
-10.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $157M | -8.2% |
| FY2024 (proj) | $160M | -5.9% |
| FY2025 (proj) | $163M | -3.7% |